|Articles|May 17, 2021
Disruption without interruption: Transitioning Rare Disease HUB & NCP Programs
Author(s)RareMed Solutions
Transitioning a rare disease HUB or NCP program to a rare-focused partner can yield major service quality improvements without program disruption.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
How Specialty Growth and Cold Chain Demand Are Rewriting Distribution Strategy
2
Why Geopolitical Supply Chain Mapping Is Critical for Life Sciences
3
Commercial Trade's Expanding Mandate: From Product Movement to Commercial Performance
4
Mid-Year Check-In: Has Prior Auth Reform Delivered?
5